First human tests begin for new arthritis drug candidate
NCT ID NCT07266207
Summary
This early-stage study tested the safety of a new oral medication called ARD-885 in healthy volunteers and people with rheumatoid arthritis. Researchers examined how different doses were tolerated and how the drug moved through the body, including whether food affected its absorption. The goal was to gather initial safety data to determine if the drug should advance to larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Guangdong, China
Conditions
Explore the condition pages connected to this study.